Description
GLP3-RT is characterized in the development literature as a triple receptor agonist, engaging the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor. That three-receptor profile is what distinguishes it from the dual and single agonists in the same structural family, and it is the reason the compound appears in comparative receptor-potency work rather than as a substitute for them.
Investigated in in-vitro receptor binding and cell-based signaling assays for relative potency across its three targets. No human data is presented, referenced, or implied.
Supplied lyophilized for reconstitution in a laboratory setting. Identity confirmed by mass spectrometry; lot-specific purity and mass values are stated on the certificate of analysis.
Supplied strictly for laboratory research use only. Not a drug, food, cosmetic, or medical device. Not for human or animal consumption, and not for diagnostic or therapeutic use. Purchase confirms the buyer is a qualified researcher and accepts sole responsibility for lawful handling, storage, and disposal under all applicable regulations.
Specifications
| CAS Number | 2381089-83-2 |
|---|---|
| Development code | LY3437943 |
| Molecular formula | C221H342N46O68 |
| Molecular weight | 4731.33 g/mol |
| Amino acid count | 39 |
| Class | Triple GIP / GLP-1 / glucagon receptor agonist |
| Purity | ≥99% RP-HPLC |
| Form | Lyophilized powder |
| Presentation | 10 vials × 10mg |
| Storage | −20°C, protect from light |
